ABOUT THIS STUDY
- Type 2 Diabetes Mellitus as defined by American Diabetes Association (ADA) at least 1 year earlier.
- Patients were required to have been treated with a stable oral agent regimen involving 2 antidiabetc medications: 1 insulin secretagogue (a sulfonylurea or replabinide) and 1 insulin sensitizer (a thiazolidinedione or metformin).
- Asthma, COPD
- Smoking during the previous 6 months
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.